Des-gamma-carboxy prothrombin (DCP) as a biomarker for treatment response in hepatocellular carcinoma.

被引：1
|
作者：
Conner, Elizabeth
Chang, Jeremy
Burgoyne, Adam
机构：
[1] Univ Calif San Diego, San Diego, CA USA
[2] Univ Calif San Diego, La Jolla, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 3_SUPPL期
关键词：
283-424-425; 613-3267-9109-8855-5546; 130-540-543-4790; 613-135-2370-5109; 298-145-222-184-4809; 5; 4; 3; 2; 1854; 182; 7; 6;
D O I：
10.1200/JCO.2024.42.3_suppl.547
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：547 / 547
页数：1
相关论文
共 50 条
  • [1] DES-GAMMA-CARBOXY PROTHROMBIN AND ANGIOGENESIS IN HEPATOCELLULAR CARCINOMA
    Shiraha, H.
    Nishina, S.
    Matsubara, M.
    Horiguchi, S.
    Iwamuro, M.
    Kataoka, J.
    Takaoka, N.
    Takaki, A.
    Nouso, K.
    Yamamoto, K.
    TUMOR BIOLOGY, 2010, 31 : S93 - S93
  • [2] Des-gamma-carboxy prothrombin (DCP) as a prognostic biomarker in patients with advanced hepatocellular carcinoma treated with atezolizumab/bevacizumab.
    Conner, Elizabeth
    Chang, Jeremy
    Burgoyne, Adam
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [3] Des-Gamma-Carboxy Prothrombin (DCP) Antagonizes the Effects of Gefitinib on Human Hepatocellular Carcinoma Cells
    Zhang, Yu-Sheng
    Chu, Jia-Hui
    Song, Zhi-Yu
    Cui, Shu-Xiang
    Qu, Xian-Jun
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2015, 35 (01) : 201 - 212
  • [4] ABNORMAL PROTHROMBIN (DES-GAMMA-CARBOXY PROTHROMBIN) IN HEPATOCELLULAR-CARCINOMA
    NAKAO, A
    VIRJI, A
    IWAKI, Y
    CARR, B
    IWATSUKI, S
    STARZL, E
    HEPATO-GASTROENTEROLOGY, 1991, 38 (05) : 450 - 453
  • [5] Plasma des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers of hepatocellular carcinoma.
    Kamel, LN
    Akl, S
    Bibawi, H
    Kahla, H
    CLINICAL CHEMISTRY, 2002, 48 (06) : A20 - A20
  • [6] Significance of Des-gamma-carboxy Prothrombin Production in Hepatocellular Carcinoma
    Fujikawa, Tatsuya
    Shiraha, Hidenori
    Yamamoto, Kazuhide
    ACTA MEDICA OKAYAMA, 2009, 63 (06) : 299 - 304
  • [7] DES-GAMMA-CARBOXY PROTHROMBIN IS A PREDICTIVE MARKER IN THE TREATMENT OF HEPATOCELLULAR CARCINOMA WITH SORAFENIB
    Ueshima, Kazuomi
    Kudo, Masatoshi
    HEPATOLOGY, 2010, 52 (04) : 1182A - 1183A
  • [8] Des-gamma-carboxy prothrombin-IgM immune complex as novel biomarker for hepatocellular carcinoma
    Beneduce, L.
    Pesce, G.
    Gallotta, A.
    Fassina, G.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S96 - S97
  • [9] DES-GAMMA-CARBOXY PROTHROMBIN AND PROLIFERATIVE ACTIVITY OF HEPATOCELLULAR-CARCINOMA
    SUEHIRO, T
    MATSUMATA, T
    ITASAKA, H
    TAKETOMI, A
    YAMAMOTO, K
    SUGIMACHI, K
    SURGERY, 1995, 117 (06) : 682 - 691
  • [10] Des-gamma-carboxy prothrombin is an autologous growth factor for hepatocellular carcinoma
    Shiraha, H.
    Suzuki, M.
    Fujikawa, T.
    Ueda, N.
    Takaoka, N.
    Nakanishi, Y.
    Takaki, A.
    Shiratori, Y.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S117 - S117
12345